Replies to post #252758 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

That is an absurd buyout valuation for Brilacidin. I have no doubt that B-ABSSSI alone can be sold for much more than $0.50 per share.

OM and IBD are very high potential indications with very low chance of failure due to adverse events. I am betting there are buyout offers available...they may be lower than what management will accept but are higher than the $0.50 you suggest.